Neurosurgery · 2007 · 40 citations · 27 references
Life SciencesGeneticsGenetic EpidemiologyMedical GeneticsNeurogeneticsCerebrovascular DiseaseGenetic RiskGenetic Risk FactorsGenotype-phenotype Association AnalysisIntracerebral HemorrhageStrokeApoe GeneticsApolipoprotein E Genotype RiskApolipoprotein E VariantsBrain Arteriovenous Malformation ResectionSymptomatic Intracranial HemorrhageTumor Necrosis Factor Alpha VariantsTumor Necrosis Factor Gene VariantsTumor Necrosis Factor Genetics
OBJECTIVE: We previously reported specific genotypes of polymorphisms in two genes, tumor necrosis factor-alpha (TNF-alpha-238G > A) and Apolipoprotein E (ApoE e2), as independent predictors of new intracranial hemorrhage (ICH) in the natural course of untreated brain arteriovenous malformations. We hypothesized that the risk of posttreatment ICH would also be greater in patients with brain arteriovenous malformations with these genotypes. METHODS: Two hundred fifteen patients undergoing brain arteriovenous malformation treatment (embolization, arteriovenous malformation resection, radiosurgery, or any combination of these) were genotyped and followed longitudinally. Association of genotype with new symptomatic ICH after initiation of treatment was assessed using Cox proportional hazards adjusted for treatment type, demographics, and established ICH risk factors censored at the time of the last follow-up evaluation or death. RESULTS: The cohort was 48% male and 55% Caucasian, and 52% had an ICH before the initiation of treatment; the mean age +/- standard deviation was 36.6 +/- 17.2 years. Posttreatment ICH occurred in 34 (16%) patients with a median follow-up period of 1.9 years (interquartile range, 1.6 yr). After adjustment, the risk of posttreatment ICH was greater for TNF-alpha-238 AG genotype (hazard ratio [HR], 3.5; 95% confidence interval [CI], 1.3-9.8; P = 0.016) and ApoE e2 (HR, 3.2; 95% CI, 1.0-9.7; P = 0.042). Similar trends for the TNF-alpha-238 AG genotype were seen in surgery (HR, 4.2; 95% CI, 0.6-28.8; P = 0.14) and radiosurgery subsets (HR, 3.8; 95% CI, 0.7-19.4; P = 0.11). An effect of ApoE e2 was seen in radiosurgery subsets (HR, 10.9; 95% CI, 1.3-93.7; P = 0.030), but not in surgery subsets (HR, 1.4; 95% CI, 0.3-7.4; P = 0.67). CONCLUSION: Despite a variety of different mechanisms for posttreatment hemorrhage, these data suggest that the TNF-alpha and ApoE genotypes may contribute common phenotypes of enhanced vascular instability that increase the risk of hemorrhagic outcome.
27
A proposed grading system for arteriovenous malformations
Robert F. Spetzler, Neil A. Martin · Journal of neurosurgery · 1986 · 2.5K citations
Medicine, Neurosurgery, Surgery +10
Gene-expression profile of the ageing brain in mice
Cheol‐Koo Lee, Richard Weindruch, Tomas A. Prolla · Nature Genetics · 2000 · 1.1K citations
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation
Christian Stapf, Henning Mast, Robert R. Sciacca et al. · Neurology · 2006 · 784 citations
Medicine, Neurosurgery, Surgery +12
Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation
Henning Mast, William L. Young, Hans‐Christian Koennecke et al. · The Lancet · 1997 · 487 citations · Full text
Medicine, Neurosurgery, Surgery +11